Back in the 1990s and early 2000s, red wine—and its leading bioactive compound, resveratrol—became famous. Long before social media, resveratrol was officially trending.
With a spotlight on 60 Minutes and mentions by Oprah Winfrey, resveratrol gained popularity for its purported longevity-boosting properties and its link to the so-called French paradox—the theory that French people have a lower risk of heart disorders despite their love of wine, butter, and croissants.
Seemingly overnight, red wine became “health in a bottle”—and people were thrilled that they could pop open a Pinot and live longer.
But 20,000 research studies and decades later, red wine hasn’t quite panned out as the longevity elixir people hoped for. While resveratrol is still widely used in anti-aging supplements, the research has produced conflicting results. Some early findings were wildly promising—and many others, profoundly underwhelming (especially in humans).
So, is this just a case of flawed clinical trials—or is resveratrol truly a dud? In this article, we’ll take a deep dive into the science behind resveratrol: what it is, what it does, and what the research really says about its role in health and longevity—plus some better options that have more evidence behind them.
The Science Behind Resveratrol: What We Know
First things first: what exactly is resveratrol?
Famously found in red grapes and wine (as well as peanuts, cocoa, and berries), resveratrol is a polyphenolic compound known as a stilbene that has exhibited antioxidant, anti-inflammatory, and free radical scavenging properties.
It has been studied for its role in supporting cognitive function, cardiovascular health, and aspects of longevity—including sirtuin activity.
Sirtuins are enzymes that help repair DNA, boost mitochondrial function, activate antioxidant pathways, and respond to cellular stress. One of resveratrol’s first claims to fame was its link to longevity by activating SIRT1—a sirtuin involved in maintaining cellular and mitochondrial health. Resveratrol also helps with autophagy, another longevity-supporting process that can be imagined as our body’s trash and recycling program. Autophagy clears out damaged cells and cell parts. When autophagy is impaired, dysfunctional cells accumulate, contributing to aging and disease.
Another important mechanism involves resveratrol’s ability to activate AMPK (AMP-activated protein kinase). AMPK is an enzyme that acts as a sensor for low energy levels inside cells. When this occurs, AMPK works to restore energy balance inside our cells by altering metabolism to pull glucose from the blood into cells for energy. You might think of AMPK as your internal fuel gauge—when energy runs low, it flips a metabolic switch to refuel the system. Essentially, AMPK acts as a “metabolic master switch” in the body, and resveratrol can activate this process and mimic these low-energy states (like those seen in caloric restriction, which are also thought to promote longevity).
The discovery of these mechanisms led to scientists testing the effects of resveratrol in yeast and animals.
One landmark study from 2006 found that resveratrol significantly increased the survival of middle-aged mice fed a high-calorie, high-fat diet, reducing their risk of death by 31%. Other beneficial changes seen in resveratrol-supplemented mice included better insulin sensitivity, improved motor function, and increased mitochondrial numbers.
Preclinical studies in cell-based and animal models have also shown longer lifespans in yeast and worms and potential improvements to cardiovascular and cognitive health.
While many of the most promising findings come from animal studies, some small human trials have also shown promise. A randomized double-blind crossover study published in Cell Metabolism in 2012 found that 11 obese but otherwise healthy men experienced beneficial metabolic changes after supplementing with 150mg of resveratrol for 30 days. These benefits included AMPK and SIRT1 activation, improved mitochondrial function, and reduced blood glucose, blood pressure, and inflammation.
Another study found that older adults who took 200mg of resveratrol daily for 26 weeks had improved brain connectivity and blood flow, along with preserved hippocampal volume—the brain region most associated with learning and memory. A third found that supplementing with 75mg of resveratrol daily for 14 weeks led to significant improvements in cerebrovascular health and cognitive performance in post-menopausal women. A fourth, larger clinical trial of 472 older adults found that resveratrol significantly improved glucose and insulin metabolism, reduced inflammation, and improved lipid profiles and kidney function.
Although some of these early human trials are promising, others have not always replicated the results, making it difficult to draw definitive conclusions about long-term health benefits. Let’s take a look at why these discrepancies may occur.
The Reality Check: Major Limitations of Resveratrol Research
One of the most glaring issues with resveratrol research has to do with bioavailability—or lack thereof.
Research shows that less than 1% of resveratrol reaches the bloodstream unchanged, as it is rapidly metabolized and eliminated from the body.
One small study found that the majority of the resveratrol taken orally ended up in the urine, with only trace amounts remaining in the bloodstream, suggesting that its absorption and effectiveness are limited. That said, this study found that resveratrol accumulates in the cells lining the digestive tract, where it—and its metabolites—could still potentially exert beneficial effects.
Plus, many resveratrol supplements may use a less bioavailable form. Many contain a blend of the two forms of resveratrol: cis-resveratrol and trans-resveratrol. Trans-resveratrol is the more bioavailable form of the compound, meaning your body can absorb and utilize it more effectively, while cis-resveratrol is the form that is not as readily absorbed.
Other factors contributing to conflicting results include highly variable dosing protocols (ranging from 5mg to 5,000mg), small sample sizes, and short study durations in clinical trials. Plus, there are discrepancies in the ability to translate preclinical or animal research to human doses—meaning that animals are often given higher doses of resveratrol that may not be realistic or achievable for humans.
This lack of standardization across studies, combined with bioavailability issues and different forms of resveratrol used, leads to these mixed or underwhelming results in human studies.
For example, one clinical trial with 24 obese but otherwise healthy men found that taking 150mg of resveratrol for four weeks did not produce any meaningful results. There were no effects on glucose or insulin metabolism, blood pressure, lipid oxidation, or inflammatory or metabolic biomarkers. In fact, the primary endpoint examined—insulin sensitivity—actually worsened.
Although resveratrol has shown potential in some studies, the inconsistent results and problems with bioavailability in humans cause some complications with interpreting the true benefits of resveratrol. As with many supplements—especially in the anti-aging and longevity space—larger studies that are well-controlled are needed to fully understand resveratrol’s effects on human health.
Why Resveratrol Supplements May Not Be Trustworthy
This brings us to another critical issue—the challenges with quality control, stability, and safety of resveratrol supplements.
As the wellness and supplement industry continues to expand, so does the risk of poor quality control, mislabeling, contamination, or even outright fraudulent products. Studies have found that what’s listed on the label doesn’t always match what’s inside the bottle—not just for resveratrol, but the supplement industry as a whole.
Even when trustworthy supplement brands follow best practices in manufacturing, resveratrol still has inherent issues with stability. Research shows that trans-resveratrol is sensitive to light, oxygen, pH, and temperature—meaning it can degrade when exposed to high temperatures, light, or alkaline conditions (above a pH of 6.8). For context, the human body’s typical pH range is 7.35-7.45, so our natural internal environment may already be pushing resveratrol toward instability after consumption.
Research also indicates that there are interindividual differences in trans-resveratrol metabolism based on what gut microbiota you have. In this small study, people with certain gut bacterial strains had differences in resveratrol metabolism, adding yet another layer of variability to its already inconsistent bioavailability.
There are also potential safety concerns with drug interactions. Resveratrol may interfere with anti-coagulant medications that slow blood clotting, such as warfarin, which increases the risk of bleeding. It may also lower blood pressure, so combining it with antihypertensive drugs could potentially lead to dangerously low blood pressure.
In short, even if resveratrol can work (and the mechanisms suggest it might), the ongoing challenges around formulation, bioavailability, safety, and stability make consistent results and therapeutic doses hard to achieve, affecting both the outcomes of clinical trials and real-world results.
The Gold Standard Perspective: What Science Actually Supports
According to a 2024 systematic review of 104 randomized controlled trials with 4,800 participants, 67% of studies showed positive effects of resveratrol supplementation, mainly for heart, metabolic, and cognitive health. However, many of these studies have limitations, such as small sample sizes or short study durations, which have made it challenging for resveratrol supplements to be recommended for clinically meaningful uses.
Current research indicates that resveratrol holds promise for reducing certain inflammatory markers, supporting cardiometabolic health (like glucose metabolism and blood pressure), and providing neuroprotective benefits.
That said, resveratrol is not the anti-aging miracle that was once hoped for. While preclinical studies using cells and animals are valid steps in research, the media has a tendency to overstate these findings and extrapolate them to humans without sufficient evidence.
The European Food Safety Authority notes that a daily intake of up to 150 mg of trans-resveratrol is considered safe for adults. However, the only approved health claim is its antioxidant activity, which highlights how limited the established benefits truly are. So, while red wine won’t make you live longer (you’d need to drink about 20 liters to get 500mg of resveratrol), resveratrol may still offer some benefits for inflammatory and metabolic conditions.
A Better Approach: Evidence-Based Alternatives
So, are there better options to consider that don’t have the same stability and bioavailability concerns?
Precursors to NAD+ (nicotinamide adenine dinucleotide), like nicotinamide riboside (NR), act on pathways similar to resveratrol, including activating sirtuins and promoting autophagy.
Nicotinamide riboside (NR) has been shown to effectively and safely raise blood NAD+ levels without significant side effects. Clinical trials suggest that NR supports heart health, brain health, and muscle health.
Since sirtuins rely on NAD+—an essential coenzyme required by every cell—elevating NAD+ levels with compounds like NR offers a better approach than activating sirtuins indirectly through resveratrol.
Research published in Nature Communications verified the bioavailability of nicotinamide riboside, finding that a single dose of NR can elevate human blood NAD+ levels by up to 2.7-fold. Plus, NR is dose-dependent, meaning higher doses result in a more significant increase in NAD+ levels. Another study showed that healthy adults who took varying doses of NR (100mg, 300mg, and 1,000mg) had significantly increased levels of whole blood NAD+ by 22%, 51%, and 142%, respectively.
The Future of Resveratrol Research
Overall, resveratrol is still a promising compound—particularly for cardiometabolic, cognitive, and inflammatory conditions. However, issues with stability, inconsistent dosing, and variability in clinical trial results leave room for improvement.
Large-scale, long-term randomized controlled trials with standardized doses and consideration of stability and bioavailability—like adding piperine to boost absorption, for example—are necessary to fully understand just how effective resveratrol can be for human health and longevity.
While resveratrol is generally considered safe and free of significant side effects (aside from the noted drug interactions), its overall efficacy remains uncertain. Supplementing with recommended doses may not cause harm—but might not offer substantial benefits, either. For now, NAD+ precursors like NR, which have a more solid evidence base, may be a better healthy aging option.
References:
Ali Sangouni A, Abdollahi S, Mozaffari-Khosravi H. Effect of resveratrol supplementation on hepatic steatosis and cardiovascular indices in overweight subjects with type 2 diabetes: a double-blind, randomized controlled trial. BMC Cardiovasc Disord. 2022;22(1):212. Published 2022 May 10. doi:10.1186/s12872-022-02637-2
Amri A, Chaumeil JC, Sfar S, Charrueau C. Administration of resveratrol: What formulation solutions to bioavailability limitations?. J Control Release. 2012;158(2):182-193. doi:10.1016/j.jconrel.2011.09.083
Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444(7117):337-342. doi:10.1038/nature05354
Bensa M, Vovk I, Glavnik V. Resveratrol Food Supplement Products and the Challenges of Accurate Label Information to Ensure Food Safety for Consumers. Nutrients. 2023;15(2):474. Published 2023 Jan 16. doi:10.3390/nu15020474
Bode LM, Bunzel D, Huch M, et al. In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota. Am J Clin Nutr. 2013;97(2):295-309. doi:10.3945/ajcn.112.049379
Brakedal B, Dölle C, Riemer F, et al. The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. Cell Metab. 2022;34(3):396-407.e6. doi:10.1016/j.cmet.2022.02.001
Brown K, Theofanous D, Britton RG, et al. Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities. Int J Mol Sci. 2024;25(2):747. Published 2024 Jan 6. doi:10.3390/ijms25020747
Chiba T, Kimura Y, Suzuki S, Tatefuji T, Umegaki K. Trans-Resveratrol Enhances the Anticoagulant Activity of Warfarin in a Mouse Model. J Atheroscler Thromb. 2016;23(9):1099-1110. doi:10.5551/jat.31765
Conze D, Brenner C, Kruger CL. Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults. Sci Rep. 2019;9(1):9772. Published 2019 Jul 5. doi:10.1038/s41598-019-46120-z
de Ligt M, Bergman M, Fuentes RM, et al. No effect of resveratrol supplementation after 6 months on insulin sensitivity in overweight adults: a randomized trial. Am J Clin Nutr. 2020;112(4):1029-1038. doi:10.1093/ajcn/nqaa125
European Food Safety Authority. Safety of synthetic trans-resveratrol as a novel food pursuant to Regulation (EC) No 258/97. 2016. https://www.efsa.europa.eu/en/efsajournal/pub/4368
Evans HM, Howe PR, Wong RH. Effects of Resveratrol on Cognitive Performance, Mood and Cerebrovascular Function in Post-Menopausal Women; A 14-Week Randomised Placebo-Controlled Intervention Trial. Nutrients. 2017;9(1):27. Published 2017 Jan 3. doi:10.3390/nu9010027
Howitz KT, Bitterman KJ, Cohen HY, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003;425(6954):191-196. doi:10.1038/nature01960
Johnson JJ, Nihal M, Siddiqui IA, et al. Enhancing the bioavailability of resveratrol by combining it with piperine. Mol Nutr Food Res. 2011;55(8):1169-1176. doi:10.1002/mnfr.201100117
Köbe T, Witte AV, Schnelle A, et al. Impact of Resveratrol on Glucose Control, Hippocampal Structure and Connectivity, and Memory Performance in Patients with Mild Cognitive Impairment. Front Neurosci. 2017;11:105. Published 2017 Mar 7. doi:10.3389/fnins.2017.00105
Kulkarni SS, Cantó C. The molecular targets of resveratrol. Biochim Biophys Acta. 2015;1852(6):1114-1123. doi:10.1016/j.bbadis.2014.10.005
Ma N, Zhang Y. Effects of resveratrol therapy on glucose metabolism, insulin resistance, inflammation, and renal function in the elderly patients with type 2 diabetes mellitus: A randomized controlled clinical trial protocol. Medicine (Baltimore). 2022;101(32):e30049. doi:10.1097/MD.0000000000030049
Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286. Published 2018 Mar 29. doi:10.1038/s41467-018-03421-7
Morselli E, Maiuri MC, Markaki M, et al. Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy. Cell Death Dis. 2010;1(1):e10. doi:10.1038/cddis.2009.8
Moussa C, Hebron M, Huang X, et al. Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease. J Neuroinflammation. 2017;14(1):1. Published 2017 Jan 3. doi:10.1186/s12974-016-0779-0
Pezzuto JM. Resveratrol: Twenty Years of Growth, Development and Controversy. Biomol Ther (Seoul). 2019;27(1):1-14. doi:10.4062/biomolther.2018.176
Poulsen MM, Vestergaard PF, Clasen BF, et al. High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition. Diabetes. 2013;62(4):1186-1195. doi:10.2337/db12-0975
Remie CME, Roumans KHM, Moonen MPB, et al. Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans. Am J Clin Nutr. 2020;112(2):413-426. doi:10.1093/ajcn/nqaa072
Song J, Liu L, Hao K, et al. Resveratrol elongates the lifespan and improves antioxidant activity in the silkworm Bombyx mori. J Pharm Anal. 2021;11(3):374-382. doi:10.1016/j.jpha.2020.06.005
Tabrizi R , Tamtaji OR , Lankarani KB , et al. The effects of resveratrol supplementation on biomarkers of inflammation and oxidative stress among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials. Food Funct. 2018;9(12):6116-6128. doi:10.1039/c8fo01259h
Thaung Zaw JJ, Howe PR, Wong RH. Long-term effects of resveratrol on cognition, cerebrovascular function and cardio-metabolic markers in postmenopausal women: A 24-month randomised, double-blind, placebo-controlled, crossover study. Clin Nutr. 2021;40(3):820-829. doi:10.1016/j.clnu.2020.08.025
Timmers S, Konings E, Bilet L, et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 2011;14(5):612-622. doi:10.1016/j.cmet.2011.10.002
Trammell SA, Schmidt MS, Weidemann BJ, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun. 2016;7:12948. Published 2016 Oct 10. doi:10.1038/ncomms12948
Walle T. Bioavailability of resveratrol. Ann N Y Acad Sci. 2011;1215:9-15. doi:10.1111/j.1749-6632.2010.05842.x
Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos. 2004;32(12):1377-1382. doi:10.1124/dmd.104.000885
Zupančič Š, Lavrič Z, Kristl J. Stability and solubility of trans-resveratrol are strongly influenced by pH and temperature. Eur J Pharm Biopharm. 2015;93:196-204. doi:10.1016/j.ejpb.2015.04.002